NHS warning to anyone who takes naproxen and aspirin

The NHS has warned against the combination of naproxen and aspirin with a commonly used medication, as this mix could result ...

Disarming cancer stem cells' shield makes immunotherapy more effective

Immunotherapy has revolutionized cancer care by training the immune system to detect and destroy tumors. For many patients, ...
The Malaysian Reserve

Innovent Announces First Participant Dosed in a Phase 1 Clinical Trial of IBI3011, a Recombinant Anti-Human Interleukin 1 Receptor Accessory Protein Monoclonal Antibody

This study is a single ascending dose (SAD) study to evaluate the safety, tolerability, and pharmacokinetics of IBI3011 for the first-in-human administration, so as to support the subsequent clinical ...
Le Lézard

Amyotrophic Lateral Sclerosis Market Outlook: Expanding Therapeutic Pipeline and Novel Drug Launches Propel Growth Throughout Forecast Period (2025-2034) | DelveInsight

DelveInsight's Amyotrophic Lateral Sclerosis Market Insights report includes a comprehensive understanding of current treatment practices, amyotrophic lateral sclerosis emerging drugs, market share of ...
EuropaWire

Novartis reports four-year progression-free durability for one in four Kisqali-treated metastatic breast cancer patients

Novartis announced new MONALEESA pooled analysis results showing that 25% of HR+/HER2- metastatic breast cancer patients treated first-line with Kisqali plus endocrine therapy remained ...